
Eiichi Tanaka
Articles
-
Oct 16, 2024 |
medrxiv.org | Suguru Honda |Katsunori Ikari |Eiichi Tanaka |Mayuko Fujisaki
Competing interestsS.H. and M.F. declares no conflicts of interest. K.I. has received speakers fee from Asahi Kasei Pharma Co., Astellas Pharma Inc., AbbVie Japan GK, Ayumi Pharmaceutical Corporation, Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Kaken Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Takeda Pharmaceutical Co. Ltd., Teijin Pharma Ltd, and UCB Japan Co. Ltd.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →